Medications and the Restrictive
Intervention Database System
(RIDS): Guide – October 2016
Office of Professional Practice, Senior Practitioner - Disability
Contents
Who is this document for ........................................................................................................................................... 1
Introduction ................................................................................................................................................................. 1
What type of medication is it? ................................................................................................................................... 2
Antipsychotic ................................................................................................................................................................. 2
Benzodiazepine ............................................................................................................................................................ 2
Mood Stabilisers (also known as an anticonvulsant) .................................................................................................... 2
Antidepressants ............................................................................................................................................................ 2
Hormonal ...................................................................................................................................................................... 2
How to determine whether the medication use is a chemical restraint ................................................................ 3
Appendix 1................................................................................................................................................................... 5
Antipsychotics ............................................................................................................................................................... 5
Psychostimulants .......................................................................................................................................................... 5
Menstrual suppression .................................................................................................................................................. 5
Antiandrogen and hormonal ......................................................................................................................................... 6
Anticholinergic............................................................................................................................................................... 6
Benzodiazepines .......................................................................................................................................................... 6
Sedative ........................................................................................................................................................................ 7
Antidepressants ............................................................................................................................................................ 7
Mood stabilisers ............................................................................................................................................................ 8
Who is this document for
This document is for?
What is important?
Actions required
Authorised Program Officer
All
Approve as Restrictive Interventions (chemical restraint)
Disability Service Provider
All
Ensure compliance with reporting on RIDS
Direct support workers
All
For information and to ensure compliance and
understanding
Introduction
The following guide and the medication list have been written to answer the most frequently asked questions by
disability service providers. The reporting of chemical restraint on the Restrictive Intervention Data System (RIDS)
is a requirement of the Disability Act 2006.
The Disability Act states that:
• the Senior Practitioner is generally responsible for ensuring that the rights of persons who are subject to
restrictive interventions and compulsory treatment are protected and that appropriate standards in relation to
restrictive interventions and compulsory treatment are complied with;’ (section 23.2(a)).
This includes chemical restraint as defined in the Act:
• ‘the use, for the primary purpose of the behavioural control of a person with a disability, of a chemical substance
to control or subdue the person but does not include the use of a drug prescribed by a registered medical
practitioner for the treatment, or to enable the treatment, of a mental illness or a physical illness or physical
condition’.
For further information contact: The Office Professional Practice /Senior Practitioner Disability on (03) 90968427 or
email office of [email protected]
Ensure all staff are aware of the side effects of all the medications a person in their care is taking. (Product
information can be obtained from your local pharmacist).
What type of medication is it?
Antipsychotic
This is a group of medications used in the treatment of psychosis. They can reduce or eliminate delusions,
hallucinations and thought disorders.
Benzodiazepine
This is a group of medications depress the central nervous system and have a calming sleep promoting or sedating
effect. They can be used to manage side effects of other medications, to manage seizures, short term treatment to
manage anxiety disorders and sleep disturbance.
Mood Stabilisers (also known as an anticonvulsant)
This is a group of medications used in the treatment of mood disorders such as depression and bi-polar illness.
They are also used to treat seizures and seizure disorder such as epilepsy. Some of the medications used to treat
epilepsy may have a mood stabilising effect.
Antidepressants
This is a group of medications used to treat depression, some may also assist in managing anxiety or obsessive
compulsive disorder and others may help when sleep disturbance is also experienced with depression.
Men - This group of medications may be given as a means of deliberately reducing sexual arousal.
Hormonal
Women - This is a group of medications used to treat a range of gynecological issues. They may be used for
contraception i.e. IUD (inter uterine device). They may also be used for menstrual suppression, (to stop her period).
Men - This group of medications may be given as a means of deliberately reducing sexual arousal.
Medications and the Restrictive Intervention Database System (RIDS): Guide – January 2016
2
How to determine whether the medication use is a chemical
restraint
Sometimes, it is difficult for disability services to clearly determine when the use of a prescribed medication is a
chemical restraint. The Senior Practitioner-Disability office’s practitioners have developed the following questions to
assist service providers’ understanding of when a chemical restraint has occurred.
Helpful question
Answer
Action
Does the person have a diagnosis
of mental illness in writing signed by
a medical practitioner, psychiatrist
or General Practitioner (GP)
prescribed for treatment of this
mental illness?
Yes
• Do not report on RIDS if this medication is for the treatment
of their mental illness.
• Ensure that this person & their medications and monitored
by a Medical Practitioner (MP).
• If the person has any behaviours of concern develop a
Behaviour Support Plan (BSP), this will assist consistency
and monitoring of interventions for the person.
No
• Develop a Behaviour Support Plan (BSP) and report on
RIDS.
• Discuss with the Medication Practitioner if a referral to a
specialist is required for diagnosis and medication review.
• Continue the medication reviews by a Medical Practitioner
on an annual basis or before if necessary.
The community norm is that a General Practitioner (GP) may diagnose and treat some psychiatric conditions;
however the complexities of the person’s disability may require specialist knowledge.
The Senior Practitioner - Disability is recommending anyone who is taking psychotropic medications should be
receiving regular comprehensive reviews by a registered Medical Practitioner (MP).
Helpful question
Answer
Action
Is the medication prescribed for the
treatment of a physical condition
such as epilepsy? (ask their treating
doctor)
Yes
• Do not report on RIDS if this medication is for treatment of a
medical condition; ensure regular review by a Medical
Practitioner, referral to a specialist may be necessary.
No
• Develop a Behaviour Support Plan (BSP) and report on
RIDS.
• Discuss with the General Practitioner if a referral to a
Medical Practitioner for diagnosis and medication review is
appropriate.
• Continue the medication reviews on an annual basis or
before if necessary.
Helpful question
Answer
Action
Is the medication only given for
sedation to enable a medical or
dental procedure and not for
sedation at any other time?
Yes
• Do not report on RIDS this is to enable the treatment of the
person with a disability
No
• Develop a Behaviour Support Plan (BSP) and report on
RIDS
• Continue the medication reviews on an annual basis or
before if necessary.
Medications and the Restrictive Intervention Database System (RIDS): Guide – January 2016
3
Helpful question
Answer
Action
Does the woman have a medical
condition diagnosed by a registered
medical practitioner?
Yes
• Do not report on RIDS this is for treatment of a medical
condition
No
• Develop a Behaviour Support Plan (BSP) and report on
RIDS
• Ask General Practitioner for a referral to a Registered
Medical Practitioner for diagnosis and medication review.
Helpful question
Answer
Action
Does the man have a history of
problematic sexual behaviours? Is
the medication prescribed to reduce
his sexual arousal and associated
behaviour?
Yes
• Develop a Behaviour Support Plan (BSP) and report on RIDS
• Contact our office on 90968427, contact the Centre for
Forensic Dual Disability Service on and follow this hyperlink
to our practice guide http://www.dhs.vic.gov.au/about-thedepartment/our-organisation/organisational-structure/ourgroups/office-of-professional-practice/research-andevaluation-opp/senior-practitioner-disability-anti-libidinalmedication-use/Anti-libidinal-medication-use-in-people-withintellectual-disability.pdf
Please note: anti libidinal agents should only be used as an
adjunct to psychological treatment. They carry a significant side
effect profile and are subject to strict pre testing and on-going
monitoring.
No
• If he has problematic sexual behaviours but isn’t on
medication. You might need support to understand the
nature of the problem and how to manage the behaviour in
the least restrictive way.
Medications and the Restrictive Intervention Database System (RIDS): Guide – January 2016
4
Appendix 1
Antipsychotics
Effective in eliminating or reducing psychotic symptoms such as delusions, hallucinations and thought
disorders.
Type of medication
Generic names
Product name
Typical antipsychotic
medications: older style
medications
Chlorpromazine
Largactil
Haloperidol
Serenace
Pericyazine
Neulactil
Trifluoperazine hydrochloride
Stelazine
Amisulpride
Solian Tablets and Solution
Aripiprazole
Abilify
Olanzapine
Zyprexa,
Atypical antipsychotic
medications: newer style
medications
Zyprexa IM
Quetiapine fumarate
Seroquel
Risperidone
Risperdal
Ziprasidone
Geodan
Paliperidone
Invega Prolonged release tablets
Asenapine Maleate
Saphris Wafer
Psychostimulants
Medications used to suppress overactive behaviour
Type of medication
Generic names
Product name
Other central nervous systems
agents
Atomoxetine hydrochloride
Strattera
Dexamphetamine sulfate
Dexamphetamine Tablets
Lisdexamfetamine dimesilate
Vyvanse
Methylphenidatehydrochloride
Ritalin 10
Ritalin LA”
Attenta Concerta Extended-Release
Tablet
Menstrual suppression
Medications used to stop women having their menstrual cycle
Type of medication
Generic names
Product name
Gonadal Hormones
Medroxyprogesterone acetate
Depo-Provera Depo-Ralovera
Provera
Norethisterone
Primolut N
Medications and the Restrictive Intervention Database System (RIDS): Guide – January 2016
5
Type of medication
Combined oral contraceptive
agents
Generic names
Product name
Oestrogens, conjugated
Premarin Tablets
Mestranol
Norinyl-1
Antiandrogen and hormonal
Medications used to suppress libido
Type of medication
Generic names
Product name
Gonadal Hormones
Cyproterone acetate
Combined oral contraceptive
agents
Ethinyloestradiol
Androcur
Cyprone
Procur
Diane-35 ED (others also have a
women’s name and 35)
Brevinor
Brevinor-1
Synphasic”
Levlen ED
Microgynon 30
Microgynon 30 ED
Microgynon 50 ED
Anticholinergic
Medications used to treat side effects caused by antipsychotic medications
Type of medication
Generic names
Product name
Movement disorders
Benzhexol hydrochloride
Artane
Benztropine mesylate
Benztrop
Cogentin
Akineton
Biperiden hydrochloride
Benzodiazepines
Medications that depress the central nervous system and have a calming sleep promoting effect
Type of medication
Generic names
Product name
Antianxiety agents
Alprazolam
Alprax
Alprazolam-DP
Kalma
Xanax
Clobazam
Frisium
Diazepam
Antenex
DiazepamElixir10mg/10ml
Diazepam-DP
Ducene
Valium
Medications and the Restrictive Intervention Database System (RIDS): Guide – January 2016
6
Type of medication
Generic names
Product name
Lorazepam
Valpam
Ativan
Oxazepam
Zopiclone
Alepam
Murelax
Serepax
Paxam
Rivotril
Alodorm
Mogadon
Normison
Temaze
Temtabs
Imovane
Type of medication
Generic names
Product name
Other central nervous system
agents
Melatonin
Melatonin
Anticonvulsants
Clonazepam
Sedatives, hypnotics
Nitrazepam
Temazepam
Sedative
Medications used to promote sleep
Antidepressants
Medications used in the treatment of depression and other mood disorders such as bi-polar illness
Type of medication
Generic names
Product name
Paroxetine hydrochloride
Aropax
Extine
Paroxetine-DZ
Paxtine
Zoloft
Concorz
Eleva
Sertraline Winthrop
Sertraline-DP
Xydep
Endep
Sertraline hydrochloride
Amitriptyline hydrochloride
Citalopram hydrobromide
Desvenlafaxine
Celapram
Cipramil
Citalopram Winthrop
Talam
Talohexal
Anafranil
Placil
Pristiq extended release tablets
Dothiepin hydrochloride
Dothep
Clomipramine hydrochloride
Medications and the Restrictive Intervention Database System (RIDS): Guide – January 2016
7
Type of medication
Generic names
Product name
Dothiepin
Dothep
Prothiaden
Deptran
Sinequan
Andepra Capsules
Doxepin hydrochloride
Duloxetine
Escitalopram oxalate
Fluvoxamine maleate
Fluoxetine
Mirtazapine
Moclobemide
Venaflaxine
Esipram
Lexapro
Faverin
Luvox
Movox
Voxam
Fluoxetine-DP
Lovan
Prozac
Zactin
Avanza
Avanza SolTab
Axit
Mirtazapine-DP
Mirtazon
Amira
Arima
Aurorix
Clobemix
Efexor
Efexor-XR
Mood stabilisers
Medications effective in mood disorders such as depression or bi-polar illness/some medications used for
the treatment of epilepsy have a mood stabilising effect
Type of medication
Generic names
Product name
Anticonvulsants
Carbamazepine
Phenytoin sodium
Carbamazepine Sandoz
Carbamazepine-BC
Tegretol
Teril
Gabahexal
Neurontin
Dilantin
Lacosamide
Vimpat
Lamotrigine
Levetiracetam
Lamictal
Lamogine
Lamotrigine-DP
Seaze
Keppra
Oxcarbazepine
Trieptal Oral suspension
Gabapentin
Medications and the Restrictive Intervention Database System (RIDS): Guide – January 2016
8
Type of medication
Generic names
Product name
Sodium Valproate
Epilim
Valpro
Topamax
Topiramate
Antipsychotic agents
Lithium carbonate
Lithicarb
Quilonum SR
To receive this publication in an accessible format phone 9096 1903, using the National
Relay Service 13 36 77 if required, or email [email protected]
Authorised and published by the Victorian Government, 1 Treasury Place, Melbourne.
© State of Victoria, Department of Health and Human Services September 2016
ISBN/ISSN
ISBN 978-0-7311-7072-2 (pdf)
Available at www.dhs.vic.gov.au/officeofprofessionalpractice
Medications and the Restrictive Intervention Database System (RIDS): Guide – January 2016
9